Home  »  Stock   »  Defying the odds and beating analyst forecasts: Co...

Defying the odds and beating analyst forecasts: Cogent Biosciences Inc. (COGT)

Let’s start up with the current stock price of Cogent Biosciences Inc. (COGT), which is $14.64 to be very precise. The Stock rose vividly during the last session to $14.72 after opening rate of $13.32 while the lowest price it went was recorded $13.19 before closing at $13.35.Recently in News on January 9, 2023, Cogent Biosciences Announces Planned 2023 Milestones for Bezuclastinib and Emerging Portfolio of Selective and Potent Targeted Cancer Therapeutics. Demonstrate significant progress toward leadership in Systemic Mastocytosis (SM), including mid-year Part 1 results from Phase 2 APEX trial in AdvSM patients and initial clinical data in 2H23 from Phase 2 SUMMIT trial in NonAdvSM patients. You can read further details here

Cogent Biosciences Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $14.72 on 01/24/23, with the lowest value was $10.93 for the same time period, recorded on 01/03/23.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


Cogent Biosciences Inc. (COGT) full year performance was 91.37%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Cogent Biosciences Inc. shares are logging -18.98% during the 52-week period from high price, and 286.28% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $3.79 and $18.07.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 598262 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Cogent Biosciences Inc. (COGT) recorded performance in the market was 26.64%, having the revenues showcasing 4.57% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 961.41M, as it employees total of 121 workers.

Market experts do have their say about Cogent Biosciences Inc. (COGT)

During the last month, 0 analysts gave the Cogent Biosciences Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 13.16, with a change in the price was noted -1.28. In a similar fashion, Cogent Biosciences Inc. posted a movement of -8.04% for the period of last 100 days, recording 844,668 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for COGT is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Technical breakdown of Cogent Biosciences Inc. (COGT)

Raw Stochastic average of Cogent Biosciences Inc. in the period of last 50 days is set at 98.12%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 98.07%. In the last 20 days, the company’s Stochastic %K was 95.00% and its Stochastic %D was recorded 87.85%.

Bearing in mind the latest performance of Cogent Biosciences Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 26.64%. Additionally, trading for the stock in the period of the last six months notably improved by 30.25%, alongside a boost of 91.37% for the period of the last 12 months. The shares increased approximately by 15.64% in the 7-day charts and went down by 32.97% in the period of the last 30 days. Common stock shares were driven by 4.57% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts